Title:

Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients withHER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial

Author:

Aman U Buzdar,Vera J Suman,Funda Meric-Bernstam,A Marilyn Leitch,Matthew J Ellis,Judy C Boughey,Gary Unzeitig,Melanie Royce,Linda M McCall,Michael S Ewer,Kelly K Hunt

Publication:

The Lancet Oncology

Publisher:

Elsevier

Date:

December 2013

Copyright © 2013, Elsevier

 User ID  
 
 Password  
 
 Enable Auto Login
Forgot Password/User ID?
If you're a copyright.com user, you can login to RightsLink using your copyright.com credentials.
Already a RightsLink user or want to learn more?

Welcome to RightsLink

Elsevier has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Elsevier content. Select the "I would like to ..." drop-down menu to view the many reuse options available to you.

I would like to...

 


To request permission for a type of use not listed, please contact Elsevier Global Rights Department.

Are you the author of this Elsevier journal article?

 

Copyright © 2014 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement.
Comments? We would like to hear from you. E-mail us at customercare@copyright.com